Relative Strength Index for "TLSA stock forecast" stands at 48, suggesting neither overbought nor oversold conditions — a zone that can precede directional moves. Barclays analyst Dan Levy recently told CNBC that Tesla's 29% September rally mirrors the retail-driven mania of 2020 and 2021, with a crucial difference: this time, the fundamentals might support the hype. Tiziana Life Sciences (TLSA) raised $10 million in an initial public offering on the week of November 19th 2018. The company issued 1,000,000 shares at $9.90 per share. Laidlaw & Company (UK) Ltd. served as the underwriter for the IPO. Analysts caution that "TLSA stock forecast" short-term price stability hinges on upcoming regulatory communications, which historically have triggered sharp market reactions.
